Skip to main content

Remote Job Finders (RJF)

Pfizer CEO Calls Trump’s Pharma National Security Concerns ‘Legitimate’

Nevertheless, Albert Bourla has been lobbying the U.S. government—as high as President Donald Trump himself—to skip the pharmaceutical industry tariffs, which Trump has threatened, in part as a way to shore up U.S. national security.

Tariff-Triggered Recession Fears, Fallout From HHS Cuts, Knockoff GLP-1s and More

A consumer-driven weight loss market could put pharma at greater risk if a recession hits; the continued turmoil at FDA and other HHS agencies magnifies the uncertainty facing the industry; Lilly files a lawsuit against a med spa selling its drugs; and more.
Scroll to top